Jupiter Research Capital (Asia) Ltd’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,068
Closed -$742K – 1122
2026
Q2
$742K Buy
+2,068
New +$632K 0.08% 298

Other funds holding WST

Jupiter Research Capital (Asia) Ltd's WST Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 2,068 shares — an estimated $742K sold.

Jupiter Research Capital (Asia) Ltd first reported a position in WST in Q2 2026 and held it in 1 quarter. The position peaked at $742K in Q2 2026. 830 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Jupiter Research Capital (Asia) Ltd sold 2,068 West Pharmaceutical shares in Q3 2026, an estimated $742K.
  • Jupiter Research Capital (Asia) Ltd first reported a position in West Pharmaceutical in Q2 2026 and held it in 1 quarter.
  • Jupiter Research Capital (Asia) Ltd's West Pharmaceutical position peaked at $742K in Q2 2026.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.